Contineum Therapeutics
Clinical trials sponsored by Contineum Therapeutics, explained in plain language.
-
New MS pill tested as add-on therapy in major trial
Disease control CompletedThis study tested whether adding an oral medication called PIPE-307 to existing multiple sclerosis treatments could help control the disease. About 182 adults with relapsing-remitting MS took either one of two doses of PIPE-307 or a placebo pill for about 30 weeks. Researchers me…
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Early test of new pill for chronic pain shows promise
Symptom relief CompletedThis early-stage study tested a new oral medication called PIPE-791 to see if it is safe and can help reduce pain. It involved 43 adults with long-term pain from knee arthritis or low back pain. Participants tried both the drug and a placebo for four weeks each to compare their e…
Phase: PHASE1 • Sponsor: Contineum Therapeutics • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC